Commerzbank Analysts Give Fresenius Medical Care AG & Co. KGaA (FME) a €80.00 Price Target

Fresenius Medical Care AG & Co. KGaA (ETR:FME) received a €80.00 ($93.02) target price from Commerzbank in a research report issued to clients and investors on Wednesday, October 17th. The brokerage presently has a “neutral” rating on the stock. Commerzbank’s price objective would suggest a potential upside of 12.96% from the stock’s previous close.

A number of other brokerages also recently commented on FME. HSBC set a €107.00 ($124.42) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Tuesday, August 28th. Berenberg Bank set a €100.80 ($117.21) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Wednesday, July 25th. Barclays set a €86.00 ($100.00) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research note on Monday, July 16th. Goldman Sachs Group set a €98.00 ($113.95) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Friday, August 24th. Finally, Oddo Bhf set a €96.00 ($111.63) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Wednesday, August 1st. Eight investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Fresenius Medical Care AG & Co. KGaA has an average rating of “Buy” and an average price target of €90.14 ($104.82).

FME stock traded down €2.30 ($2.67) during mid-day trading on Wednesday, reaching €70.82 ($82.35). The company had a trading volume of 1,502,891 shares, compared to its average volume of 704,197. Fresenius Medical Care AG & Co. KGaA has a 12 month low of €75.53 ($87.83) and a 12 month high of €93.82 ($109.09).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

See Also: Dollar Cost Averaging

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply